SciSparc Ltd.'s stock jumped 157% following its subsidiary NeuroThera Labs receiving conditional approval from the TSX Venture Exchange. This approval allows NeuroThera to acquire a 54% stake in CliniQuantum Ltd., a company specializing in quantum-powered clinical trial data analysis. The deal involves issuing 56.6 million shares valued at approximately $9.459 million. The acquisition aims to enhance precision in clinical trial outcomes using advanced quantum simulation technology, with final closing expected by June 1 after tax rulings are resolved.
U.S. stocks reached record highs with the S&P 500 up 0.5%, driven by strong gains in AI-related companies like Snowflake, which surged 37% after exceeding earnings and revenue expectations. The market optimism followed a 60-day ceasefire extension be...
Idea Grove, a Dallas-based B2B PR and AI visibility agency, published its 2026 Trust Signals® B2B Brand Rankings, highlighting top companies across 16 technology and industrial sectors such as cybersecurity, fintech, AI automation, and manufacturing....
CrowdStrike has formed a strategic collaboration with major insurers like Coalition, Liberty Mutual, and Lockton to develop a framework addressing financial risks from frontier AI in cybersecurity. The company also expanded its presence in Germany by...
Gainsight introduced its Agentic Stack, a platform integrating AI-powered agents to help companies retain and grow customers more effectively. The new Gainsight Agent Studio allows teams to design and automate AI workflows tailored to their business,...
Dollar Tree reported first-quarter adjusted earnings of $1.74 per share, surpassing analyst estimates of $1.55. Revenue reached $4.98 billion, slightly above expectations, with net sales up 7.2% year-over-year and comparable-store sales rising 3.5%. ...
